Advertisement: Mogrify
Advertisement: Cambridge Network
Advertisement: Wild Knight Vodka
Mid banner advertisement: BDO
Barr Ellison Solicitors – commercial property
Advertisement Cambridge China Centre
Advertisement EY mid banner
7 June, 2016 - 19:54 By Tony Quested

Avita Medical widens Asia footprint with Malaysia deal

Avita Medical has continued its march through Asia with the appointment of a specialist distributor to deliver its regenerative medical devices for burns, wounds and skin conditions in Malaysia.

The move is likely to prove a springboard into other Asian territories for the Cambridge UK medical technology business as the new distributor – Mintcare – also has commercial presence in Hong Kong, Indonesia, Philippines, Sri Lanka, Thailand, and Vietnam and distributes wound care products throughout the Asia-Pacific region.

Singapore-based Mintcare will initially focus on Malaysia where the chronic skin condition vitiligo alone is reported to affect an estimated 450,000 people  chronic wounds some 180,000 patients, and large burns annually leave about 1,200 Malaysians hospitalised.

Avita Medical’s ReCell® technology works through the rapid delivery of viable cells harvested from a piece of the patient's own skin and is administered by spraying the cells onto the affected area to trigger healing.  ReCell® will be launched at an international wound care conference in Sabah, Malaysia in August.

CEO, Adam Kelliher (pictured), said the deal in Malaysia was another milestone in the company’s strategy to roll out its regenerative medical devices in key Asian markets.

In recent months, the company has announced distribution agreements with parties in China, Japan and South Korea and it has been active in Taiwan, where it donated devices following a mass casualty incident last summer in a waterpark that left some 500 people burned.

“The deal with Mintcare will give Avita Medical an active presence to deliver our innovative treatments to Malaysia, a market of 30 million people, and further underscores the significance of the broader Asian healthcare market for our company,” Kelliher said.
 
“We will keep developing our distributor network in the region so that we are well-placed to address the significant commercial opportunities in Avita.”

Newsletter Subscription

Stay informed of the latest news and features